Tumori Journal · 1986 · 13 citations · 9 references
MedicineOncologyPharmacologyCancer Drug Toxicity ManagementChemotherapyMedical OncologyAdverse Effects Of ChemotherapyFibrosisInterstitial Lung DiseasePulmonary ToxicityCancer Therapy-related Pulmonary ToxicityChemotherapy-induced Pulmonary ToxicityInterstitital Lung DiseaseLomustine TherapyLung FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis ProgressionPulmonary Toxicity Mechanisms
A case of progressive pulmonary interstitial fibrosis following adjuvant lomustine (CCNU)-5-fluorouracil therapy for a colon carcinoma is reported. A close relationship between lomustine assumption and lung damage seems to emerge from the clinical, radiologic and histologic findings presented. On the basis of this experience and previous available data from literature, pulmonary toxicity must be regarded as a possible adverse effect of lomustine therapy.
9
Cancer: Principles and Practice of Oncology
Walter G. Gunn · JAMA · 1982 · 474 citations
Medicine, Oncology, Oncology Nursing +10
Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962.
De Vita Vt, Carbone Pp, Owens Ah et al. · PubMed · 1965 · 219 citations
Medicine, Oncology, Pharmacology +14
Prediction of BCNU Pulmonary Toxicity in Patients with Malignant Gliomas
Patricia A. Aronin, M. S. Mahaley, Seth A. Rudnick et al. · New England Journal of Medicine · 1980 · 189 citations
Pharmacy, Oncology, Pharmacology +13
Cytotoxic drug-induced lung disease
H. Dirk Sostman, Richard A. Matthay, Charles E. Putman · The American Journal of Medicine · 1977 · 155 citations
Pharmacy, Pharmacology, Toxicology +10
The nitrosoureas and pulmonary toxicity
Raymond B. Weiss, Donald S. Poster, John S. Penta · Cancer Treatment Reviews · 1981 · 92 citations
Pharmacy, Pharmacology, Toxicology +11